Cargando…

Correction to “Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library”

Detalles Bibliográficos
Autores principales:	Shaikh, Faraz, Zhao, Yuguang, Alvarez, Luis, Iliopoulou, Maria, Lohans, Christopher, Schofield, Christopher J., Padilla-Parra, Sergi, Siu, Shirley W. I., Fry, Elizabeth E., Ren, Jingshan, Stuart, David I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154555/ https://www.ncbi.nlm.nih.gov/pubmed/31657917 http://dx.doi.org/10.1021/acs.jmedchem.9b01711

Ejemplares similares

Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library
por: Shaikh, Faraz, et al.
Publicado: (2019)

Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection
por: Ren, Jingshan, et al.
Publicado: (2017)

Lysosome sorting of β-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor
por: Zhao, Yuguang, et al.
Publicado: (2014)

TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders
por: Shaikh, Faraz, et al.
Publicado: (2018)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses
por: Swetha, Rayapadi G., et al.
Publicado: (2016)

Identification of novel natural compound inhibitors for human complement component 5a receptor by homology modeling and virtual screening
por: Shaikh, Faraz, et al.
Publicado: (2016)

Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
por: Gilchuk, Pavlo, et al.
Publicado: (2018)

Assembly and Budding of Ebolavirus
por: Noda, Takeshi, et al.
Publicado: (2006)

Ebolavirus comparative genomics
por: Jun, Se-Ran, et al.
Publicado: (2015)

Ebolavirus and Other Filoviruses
por: Leroy, E., et al.
Publicado: (2007)

Structural Basis for Differential Neutralization of Ebolaviruses
por: Bale, Shridhar, et al.
Publicado: (2012)

Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24
por: Ramanathan, Palaniappan, et al.
Publicado: (2023)

Ebolavirus Evolution: Past and Present
por: de La Vega, Marc-Antoine, et al.
Publicado: (2015)

Virological diagnosis of Ebolavirus infection
por: Smith, D. W., et al.
Publicado: (2015)

Ebolavirus: Infection, Vaccination and Control
por: Ahad, Abdul, et al.
Publicado: (2022)

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
por: Kuang, Erin, et al.
Publicado: (2022)

A Shared Structural Solution for Neutralizing Ebolaviruses
por: Dias, João M., et al.
Publicado: (2011)

LigTMap: ligand and structure-based target identification and activity prediction for small molecular compounds
por: Shaikh, Faraz, et al.
Publicado: (2021)

Ebolavirus Replication and Tetherin/BST-2
por: Yasuda, Jiro
Publicado: (2012)

Discovery of an Ebolavirus-Like Filovirus in Europe
por: Negredo, Ana, et al.
Publicado: (2011)

Reston Ebolavirus Antibodies in Bats, the Philippines
por: Taniguchi, Satoshi, et al.
Publicado: (2011)

Discovery of an antibody for pan-ebolavirus therapy
por: Furuyama, Wakako, et al.
Publicado: (2016)

Risks Posed by Reston, the Forgotten Ebolavirus
por: Cantoni, Diego, et al.
Publicado: (2016)

Ebolaviruses: New roles for old proteins
por: Cantoni, Diego, et al.
Publicado: (2018)

Ecological indicators of mammal exposure to Ebolavirus
por: Schmidt, John Paul, et al.
Publicado: (2019)

Characterization of Sudan Ebolavirus infection in ferrets
por: Kroeker, Andrea, et al.
Publicado: (2017)

The roles of ebolavirus glycoproteins in viral pathogenesis
por: Ning, Yun-Jia, et al.
Publicado: (2016)

Epidemiology of Ebolaviruses from an Etiological Perspective
por: Jain, Sahil, et al.
Publicado: (2023)

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
por: Howell, Katie A., et al.
Publicado: (2017)

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
por: Murin, Charles D., et al.
Publicado: (2022)

In Silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors from Traditional Chinese Medicine
por: Chen, Kuan-Yu, et al.
Publicado: (2012)

Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
por: Wolfe, Daniel N., et al.
Publicado: (2020)

In Silico Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes
por: Zhang, Junqi, et al.
Publicado: (2023)

Roles of 2-oxoglutarate oxygenases and isopenicillin N synthase in β-lactam biosynthesis
por: Rabe, Patrick, et al.
Publicado: (2018)

Analysis of β-lactone formation by clinically observed carbapenemases informs on a novel antibiotic resistance mechanism
por: Aertker, Kristina M.J., et al.
Publicado: (2021)

Serological evidence of ebolavirus infection in bats, China
por: Yuan, Junfa, et al.
Publicado: (2012)

Testing New Hypotheses Regarding Ebolavirus Reservoirs
por: Leendertz, Siv Aina Jensen
Publicado: (2016)

Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein
por: Xiao, Julie Huiyuan, et al.
Publicado: (2018)

Pre-emptive genomic surveillance of emerging ebolaviruses
por: Postigo-Hidalgo, Ignacio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6t21ei87o3f3htd9div88ntpi2